GenomOncology

Today we announced a new partnership with Belay Diagnostics to transform CNS cancer detection and treatment! GenomOncology's Pathology Workbench is now powering the reporting of Belay's innovative Summit? liquid biopsy test - a groundbreaking approach that analyzes cerebrospinal fluid to detect genetic variants associated with central nervous system malignancies. This collaboration marks a significant advancement in the cancer diagnostics by: - Enabling faster analysis of thousands of samples monthly - Reducing laboratory overhead and accelerating review processes - Providing providers patients with quicker access to treatment considerations - Offering an alternative to traditional, more invasive diagnostic methods The integration of our data-driven platform with Belay's cutting-edge liquid biopsy technology creates a powerful solution that will help clinicians make more informed decisions and improve patient outcomes. Join us for an educational webinar on April 9th to learn about more about how Summit and Pathology Workbench are creating a more efficient and accurate workflow in CNS genetic diagnostics. Visit https://bit.ly/3DPgYOw to register. Together with Belay Diagnostics, we're proud to be at the forefront of precision oncology, transforming unusable data into actionable treatment options. #PrecisionMedicine #CancerDiagnostics #LiquidBiopsy #Genetics #CNS

Are you up to date on the latest breakthrough in brain and spinal tumor diagnostics? Join #BelayDiagnostics Honey Reddi, PhD, and GenomOncology's Matthew Stachowiak, PhD, April 9th, for an exclusive webinar exploring how the Belay Summit?? liquid assay—when integrated with GenomOncology's Molecular Pathology Workbench solution—is transforming neuro-oncology through minimally invasive diagnostics and enhanced reporting. Discover how this integrated solution: ? Detects tumor biomarkers in CSF and blood with exceptional sensitivity ? Reduces reliance on high-risk invasive procedures in neural tissues ? Enables earlier detection and real-time monitoring of treatment response ? Delivers actionable genetic insights through comprehensive reporting ? Streamlines interpretation with AI-powered variant classification Learn how this cutting-edge technology can elevate your diagnostics with faster turnaround times, improved accuracy, and enhanced patient outcomes. April 9, 2025 - 1:00PM Eastern/10AM Pacific To register visit: https://bit.ly/3DPgYOw #LiquidBiopsy #NeuroOncology #PrecisionMedicine #MolecularDiagnostics #ClinicalGenomics #CancerDiagnostics #ProfessionalDevelopment

?? Exciting news for the genomics community and beyond! In the fall of 2024, GenomOncology and Genomenon, Inc announced a strategic partnership that's transforming germline variant classification and genomic reporting. By integrating Genomenon's expertly curated Mastermind Data into GenomOncology's knowledgebase, we've created a best-in-class germline clinical reporting solution with wide-ranging applications—from whole genome and exome analysis to targeted panels for hereditary cancer and rare disease. This powerful collaboration has streamlined the entire process from VCF to reporting, eliminating cumbersome manual workflows and dramatically reducing reporting time from days to minutes. See It In Action at #ACMG2025! ?? Visit us at the GenomOncology Booth #213 ?? Meet Dr. Matthew Stachowiak, VP of Product Innovation from GenomOncology, at the Genomenon, Inc. Booth #723 on March 20 from 2-3PM Pacific Don't miss this opportunity to discover how this partnership is advancing precision medicine and improving patient care. Looking forward to connecting with fellow genomics professionals this week! #Genomics #PrecisionMedicine #VariantClassification #RareDisease #VCF #ClinicalGenomics #ACMG2025 #GenomOncology #Genomenon

Want to see how precision medicine is becoming more accessible? Check out our insightful 30-minute on-demand webinar featuring MEDITECH's Jennifer Ford, MBA and GenomOncology's James Cole as they showcase a game-changing integration that's empowering clinicians with efficient strategies to quickly match patients with relevant clinical trials. As healthcare continues its digital transformation, partnerships like this demonstrate how technology can directly improve patient outcomes through smarter, more personalized treatment planning. ??? Watch now: https://bit.ly/3Dx9aRk #PrecisionMedicine #HealthIT #ClinicalTrials #Oncology #DigitalHealth

Is your ?? multi-omics reporting workflow drowning in complexity and manual steps, delaying patient results and increasing provider burnout? ??Stop by GenomOncology's booth #213 at ACMG - American College of Medical Genetics and Genomics 2025 Annual Meeting. ??Discover how our streamlined solutions can transform your efficiency and reporting accuracy. #ACMG2025 #CancerGenomics #MolecularPathology #GenomicReporting #NGSWorkflow #PrecisionOncology #LaboratoryEfficiency ??Visit GenomOncology: https://bit.ly/43noV7T

GenomOncology's Precision Oncology Platform's API Suite combined with MEDITECH's Expanse Genomics is transforming cancer care. At Frederick Health, the results speak volumes: - 96 patients received personalized treatment modifications - 56 new clinical trial referrals generated Previously, the organization averaged two clinical trial referrals in the six months prior. How? The API Suite seamlessly integrates genomic insights directly into Expanse Genomics workflows, enabling: - Real-time treatment optimization - Targeted clinical trial matching - Precision-driven patient care ?? See the Future of Oncology Genomic Technology ?? MEDITECH Booth #972 at #HIMSS25 ?? Live demonstrations of the collaboration Deep dive into the GenomOncology technology: https://bit.ly/43noV7T #HealthTech #Oncology #PrecisionMedicine #HIMSS25 #HealthcareInnovation

Frederick Health sees spike in suggested cancer treatment changes and increase in precision medicine and clinical trial referrals using first-of-its-kind integrations between MEDITECH #Expanse #Genomics and GenomOncology precision oncology platform. ????Watch our video to learn more about Frederick Health's Genomics program: https://hubs.ly/Q038CyTy0 Read our press release to learn about Frederick Health's latest integration with GenomOncology:? https://hubs.ly/Q038B_tB0 Helen Waters Catherine Turner Rachel Wilkes, MBA, CPM Jason Patnode Jennifer Ford, MBA Garry Miller, MSHMI, MBA Rose McCarthy

MEDITECH + GenomOncology direct patient impact: "In the first six months, Frederick Health recorded?96 patients who received a treatment change?based on the advanced recommendations that target the genetics of each patient’s individual cancer.... 56 new referrals to their own clinical trials program?within the first six months.?Previously, the organization only averaged two clinical trial referrals in the six months prior to go-live. Having this information readily accessible to clinicians allows them to seek alternate treatment options, including clinical trials hosted by Frederick Health, which could both prove lifesaving and allow them to continue to treat patients in-house." Full article: https://lnkd.in/gU6mGK-8 More about MEDITECH Genomics: https://lnkd.in/g_g8zrh4 More about GenomOncology: https://lnkd.in/gbT2ZFMV cc: Jennifer Ford, MBA #oncology #genomics #precisiononcology

Enhancing patient care and driving meaningful clinical improvement is what fuels our work here at GenomOncology. Seeing these #clinicaltrial referral results from our collaboration with MEDITECH at Frederick Health will continue to promote our passion for providing data-forward solutions that show results! #CancerInformatics #PatientForwardCare #Oncology #Bioinformatics #CancerGenomics https://lnkd.in/eMFda-2e

Going to HIMSS Global Health Conference & Exhibition? Our Chief Commercial Officer, Garreth Hippe would like to connect. Tell us how you are integrating your multi-omics data. We may have ways to help enable your data to quickly and more efficiently improve patient care in oncology and beyond. Click below to schedule some time. #HIMSS25 #GeneticsReporting #Bioinformation #CancerGenetics #Genomics #MultiomicData #Pathlogy #ClinicalDataEnablement #HealthInformation